Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Wednesday, October 01

10:40 AM - 10:50 AM PT

358 - Validation of Six Androgen Production, Uptake and Conversion Genes (APUC-6) in the ECOG-ACRIN E3805 CHAARTED Prostate Cancer Trial
Speaker: Tran, Phuoc, MD, PhD - University of Texas MD Anderson Cancer Center, Houston, Texas
10:40 AM - 10:50 AM PT

364 - Improving SPR Calculation for Pediatric Patients Using a Novel Imaging Algorithm for Tissue Parameterization with Photon-Counting CT
Speaker: Zhu, Jiahua, PhD - City of Hope National Medical Center, Duarte, CA
10:45 AM - 10:50 AM PT

1134 - A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients with Unresectable and Borderline Resectable Pancreatic Cancer
Speaker: Amit, Uri, MD, PhD, MPH - Tel Aviv Medical Center, Tel Aviv, Tel Aviv
10:45 AM - 10:50 AM PT

1140 - hnRNPA1 Impedes the Anti-Tumor Immune Response Effect via Competitively Inhibiting TRIM21-Mediated Ubiquitination and Degradation of CD155
Speaker: Zhang, Lu, MS, none - Chongqing University Cancer Hospital, Shapingba, Chongqing
10:45 AM - 10:50 AM PT

1146 - A Single Automated VMAT Planning Framework for TBI, CSI and TMLI: Streamlining Workflow and Enhancing Plan Quality
Speaker: Simiele, Eric, PhD - University of Alabama at Birmingham, Birmingham, AL
10:50 AM - 10:55 AM PT

1135 - Salvage Adaptive Radiation Therapy for Locoregional Recurrence of Pancreatic Adenocarcinoma
Speaker: Padgett, Michael, MD - Washington University in St. Louis, St. Louis, MO
10:50 AM - 10:55 AM PT

1141 - Conventional Fractionated Elective Nodal Irradiation Preserves Early Antitumor Immunity and Efficacy Compared to Hypofractionated Protocols
Speaker: Sato, Genki, MD - Kyoto University Hospital, Kyoto, Kyoto
10:50 AM - 10:55 AM PT

1147 - The Role of Skull Dosimetry in Minimizing Acute Hematologic Toxicities of Brain Metastasis Patients Receiving Radiotherapy and Immunotherapy
Speaker: Ma, Jiachun, MD, PhD - Shandong Cancer Hospital and Institute, Shandong First Medical University, Jinan, Shandong
10:50 AM - 11:00 AM PT

359 - Hallmark Interferon-Alpha Response Analysis in Localized Prostate Cancer: Analysis of the NRG Oncology/RTOG 9202, 9413, 9902, 0126, and 0521 Clinical Trials
Speaker: Olson, Adam, MD, MS - UPMC Hillman Cancer Center, Pittsburgh, PA
10:50 AM - 11:00 AM PT

365 - Simultaneous T1, T2, T2*, and PDFF Estimation Using Magnetic Resonance Fingerprinting on a 1.5T MR-Linac for Head and Neck Cancer Patients
Speaker: McCullum, Lucas, BS - MD Anderson Cancer Center, Houston, TX
10:55 AM - 11:00 AM PT

1136 - Stereotactic Body Radiation Therapy vs. Surgical Resection for BCLC Stage 0 Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis
Speaker: Lee, Hye In, MD - Asan Medical Center, University of Ulsan College of Medicine, Seoul, Songpa-gu
10:55 AM - 11:00 AM PT

1142 - Focal Adhesion Kinase Targeting Enhances Anti-Tumor Immunity Following Conventionally Fractionated Radiation
Speaker: Leibowitz, Brian, PhD - University of Pittsburgh School of Medicine, Pittsburgh, PA